Skip to main content
OpenTrials
Completed

NCT Number: NCT06451224

Egyptian Arthroplasty Surgeons' Antibiotics Usage Awareness

Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are procedures successfully applied to manage various end-stage chronic hip and knee diseases, such as osteoarthritis, rheumatoid arthritis, and femoral head avascular necrosis, as well as acute conditions, such as the neck of femur fractures, with excellent long-term functional outcomes. One of the devastating complications after such a procedure is periprosthetic joint infection (PJI). Various precautions are proposed to guard against such complications; one is the administration of perioperative antibiotics. However, injudicious or misuse of antibiotics could lead to the emergence of antimicrobial resistance, further complicating this matter. This is why various scientific and research organizations have proposed guidelines and a consensus for proper antibiotic use in perioperative THA and TKA surgery.

Antibiotic prophylaxis during primary THA and TKA can reduce the risk of PJI and surgical site infections. However, there is a lack of consensus on the optimal dosages and duration of prophylaxis, and guidelines vary among institutions. Alternatives such as extended oral antibiotic prophylaxis and different antibiotic regimens are being explored. International research is needed to establish best practices and determine the potential risks of antibiotic prophylaxis during primary THA and TKA. Unfortunately, the investigators are unaware of such guidelines proposed by any Egyptian health authority to guide and control the proper utilization of antibiotics during orthoapedic practice in general and joint replacement surgeries (THA and TKA) in particular.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Assuit Faculty of Medicine

Asyut, Asyut Governorate, Egypt

About this study

This study will be an Online-based questionnaire investigating surgeons' perspectives on antibiotics utilization during primary total hip and knee arthroplasty surgeries and investigate their thoughts about the necessity for developing local guidelines.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All Egyptian registered members of the Egyptian Pelvis and Hip Society, practicing Egyptian joint replacement surgeons (performing surgeries as a leading surgeon) who are willing to participate

Exclusion criteria

  • Members not listed in the E-mail directory of the society
  • Surgeons refusing to participate
  • Young surgeons who are not practicing independently

Treatment and study plan

Questionnaire

Other

Online Questionnaire

Primary outcomes

  1. To determine the type of antibiotics administration during primary total hip and knee arthroplasty

    Time frame: 2 months

    The type of antibiotics will be determined as follows: the name of the antibiotic (brand or generic), and if single or dual antibiotics are used. These will be presented as numbers and percentages.

Secondary outcomes

  1. To determine the dose of antibiotics administered during primary total hip and knee arthroplasty

    Time frame: 2 months

    The dose of antibiotics will be determined as grams or milligrams. Furthermore, the number of doses will be reported

  2. To determine the timing of antibiotics administration during primary total hip and knee arthroplasty

    Time frame: 2 months

    Regarding the timing, preoperative antibiotic administration will be reported in minutes

  3. To determine the length of antibiotics administration during primary total hip and knee arthroplasty

    Time frame: 2 months

    the length of antibiotic administration postoperatively will be calculated in days.

Sponsors and collaborators

Lead sponsor

South Valley University

Other

Collaborators

  • Assiut University

Registry information

Official study title

Attitudes of Prophylactic Antibiotic Utilization During Primary Total Hip and Knee Arthroplasty Among Egyptian Joint Replacement Surgeons

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jun 11, 2024
Registry last updated
Oct 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.